Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Taselisib plus fulvestrant in ER+/HER2- advanced breast cancer
CTR20160894Phase 3Completed
- Sponsor
- Roche
- Start
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of taselisib / pictilisib in breast cancer, sponsored by Roche. Started Dec 2016; status: completed.
02
Drugs
taselisib / pictilisib
03
Conditions
breast cancer
Beyond the preview
Go deeper on CTR20160894.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160894.